ANNOVIS BIO (ANVS) Stock Earnings & Estimates
USA - New York Stock Exchange - NYSE:ANVS - US03615A1088 - Common Stock
3.6 USD
-0.06 (-1.64%)
3.6 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 313.09% | N/A 84.44% | N/A 51.48% | N/A 40.90% | |||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A 45.39% | N/A -11.65% | N/A -60.43% | N/A -65.92% | N/A -128.65% | N/A 81.09% | N/A 504.99% | N/A 145.61% | N/A 68.96% | |
| EBIT YoY % growth | -680K | -710K -4.41% | -1.61M -126.76% | -6.64M -312.42% | -14.54M -118.98% | -25.51M -75.45% | -45.035M -76.54% | -26.695M 40.72% | N/A -9.70% | N/A -61.09% | N/A -48.11% | N/A -67.13% | N/A 76.44% | N/A 516.20% | N/A 141.88% | N/A 78.15% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -1.90 -238.68% | -3.10 -63.16% | -6.13 -97.74% | -1.82 70.31% | N/A 24.90% | N/A -4.29% | N/A 10.55% | N/A -65.60% | N/A 81.16% | N/A 482.05% | N/A 111.41% | N/A 61.59% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.35 18.56% | -0.35 -10.50% | -0.35 -10.50% | -0.38 -3.84% | -0.42 -19.42% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -8.058M -61.22% | -9.384M -43.75% | -10.506M -15.73% | -11.628M -58.33% | N/A |
| EBIT Q2Q % growth | -8.704M -29.24% | -10.491M -66.98% | -11.302M -80.21% | -12.362M -66.27% | -17.626M -102.50% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.37 61.86% | -0.31 | -0.06 | -18.93% |
| Q2 2025 Q2Q % growth | -0.32 | -0.41 | 0.09 | 22.06% |
| Q1 2025 Q2Q % growth | -0.32 -220.00% | -0.36 | 0.04 | 11.97% |
| Q4 2024 Q2Q % growth | -0.43 80.80% | -0.34 | -0.09 | -27.55% |
| Q3 2024 Q2Q % growth | -0.97 40.49% | -0.54 | -0.43 | -80.79% |
| Q2 2024 Q2Q % growth | -0.32 70.09% | -0.64 | 0.32 | 50.15% |
| Q1 2024 Q2Q % growth | -0.10 91.60% | -0.81 | 0.71 | 87.72% |
| Q4 2023 Q2Q % growth | -2.24 -489.47% | -1.33 | -0.91 | -68.35% |
| Q3 2023 Q2Q % growth | -1.63 -75.27% | -1.11 | -0.52 | -46.56% |
| Q2 2023 Q2Q % growth | -1.07 | -1.16 | 0.09 | 8.12% |
| Q1 2023 Q2Q % growth | -1.19 -65.28% | -0.34 | -0.85 | -249.30% |
| Q4 2022 Q2Q % growth | -0.38 49.33% | -1.07 | 0.69 | 64.61% |
| Q3 2022 Q2Q % growth | -0.93 -165.71% | -1.03 | 0.10 | 10.02% |
| Q2 2022 Q2Q % growth | -1.07 -214.71% | -0.66 | -0.41 | -62.64% |
| Q1 2022 Q2Q % growth | -0.72 -56.52% | -0.59 | -0.13 | -21.70% |
| Q4 2021 Q2Q % growth | -0.75 -359.56% | -0.26 | -0.50 | -194.12% |
| Q3 2021 Q2Q % growth | -0.35 -133.33% | -0.45 | 0.10 | 22.01% |
| Q2 2021 Q2Q % growth | -0.34 | -0.38 | 0.04 | 9.91% |
| Q3 2020 Q2Q % growth | -0.15 | -0.15 | 0.00 | 1.96% |
| Q2 2020 Q2Q % growth | -0.34 | -0.15 | -0.19 | -122.22% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -20.47% | -17.38% | -6.52% | 1.29% |
| Revenue | N/A | N/A | N/A | N/A |